• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY C CALCIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY C CALCIUM Back to Search Results
Model Number 07P5730
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/03/2020
Event Type  malfunction  
Manufacturer Narrative
Patient information: sample id (b)(6): (b)(6) year old female sample id (b)(6), (b)(6) year old male sample id (b)(6), (b)(6) year old female sample id (b)(6), (b)(6) year old male sample id (b)(6), (b)(6) year old male.No further patient information was provided.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer obtained a falsely elevated alinity c calcium result for multiple patients.The customer uses a normal range of 8.5 to 10.5 mg/dl.The following results were provided: on (b)(6) 2020 - sample id (b)(6), (b)(6) year old female: 18.5 mg/dl and normal subsequent results of 8.6 and 8.7 mg/dl.On (b)(6) 2020 - sample id (b)(6), (b)(6) year old male: 15.5 mg/dl and normal subsequent results of 10.0, 9.5, 10.2 and 9.7 mg/dl.On (b)(6) 2020 - sample id (b)(6), (b)(6) year old female: 16.2 mg/dl and normal subsequent results of 9.6 and 9.2 mg/dl.(b)(6) 16.4 mg/dl.On (b)(6) 2020 - sample id (b)(6), (b)(6) year old male: 15.3 and normal subsequent result of 10.3 mg/dl.On (b)(6) 2020 - sample id (b)(6), (b)(6) year old male: 17.0mg/dl, repeat of 7.4 mg/dl and normal subsequent results of 7.9, 8.1 and 7.6 mg/dl.No impact to patient management was reported.
 
Manufacturer Narrative
A review of tickets determined that there is normal complaint activity for alinity calcium reagent ln 7p57-30/lot number 37978un19.Review of trending reports associated with the alinity c calcium assay did not identify any trends for discrepant patient results.Return testing was not completed as returns were not available.Retesting of samples at the customer site generated the expected results.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of the alinity c calcium reagent lot number 37978un19 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY C CALCIUM
Type of Device
CALCIUM
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10199926
MDR Text Key230622531
Report Number3002809144-2020-00532
Device Sequence Number1
Product Code CJY
UDI-Device Identifier00380740135409
UDI-Public00380740135409
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 10/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/23/2020
Device Model Number07P5730
Device Catalogue Number07P57-30
Device Lot Number37978UN19
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/05/2020
Initial Date FDA Received06/26/2020
Supplement Dates Manufacturer Received10/21/2020
Supplement Dates FDA Received10/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY C PROCESSING MODULE, LIST 03R67-01,; ALNTY C PROCESSING MODU, 03R67-01, (B)(6) ; SERIAL (B)(6)
Patient Age3 YR
-
-